(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

ACTIPHAGE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

ACTIPHAGE

ST13

US500000079229997

Classe

1, 5

Pedido

79229997

Registro

5777982

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

39

Atualização mais recente

27/01/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5

Data de depósito

02/02/2018

Data de registro

18/06/2019

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

02/01/2026

Última transação

27/01/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

709

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

24

Localização do titular

GB

Examinador

MIRANDA, JOHN

Unidade examinadora

N20

Localização atual

POST REGISTRATION

Titulares e representantes

Titulares

PBD Biotech Limited

Representantes

Rebecca Liebowitz VENABLE LLP

Classificação técnica

Classes Nice

Classe 1Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemicalbiochemical and biological productschemicalbiochemical and biological preparations used in science; chemical reagents; chemicals preparations for use as reagents; diagnostic preparationschemicalsreagents and chemical preparations for use in diagnostics; chemicalsreagents and chemical preparations for use in tests and testingreagents and chemical preparations for scientific purposes; diagnostic test kits for testing biological samples and foodstuffs for laboratory or research useresearch assaysall of the foregoing comprising of chemicalsreagents and chemical preparations; chemical research assays; diagnostic test kits for testing biological samples and foodstuffs for laboratory or research use and research assays for testing biological samplesall of the foregoing comprising of chemicals and chemical preparations; none being for medical or veterinary purposes

Classe 5

Medical and veterinary preparations and substances for the diagnosis of infectious diseasesblood groupingvirologyantibodiesgeneticsoncologyhepatologypharmacogeneticscardiovascular medicinerespiratory ailments; chemicalbiochemical and biological preparations and reagents for medical and veterinary purposesmedical and veterinary preparations for the diagnosis of infectious diseasesblood groupingvirologyantibodiesgeneticsoncologyhepatologypharmacogeneticscardiovascular medicinerespiratory ailments; medical and veterinary preparations being chemical reagents; medical and veterinary diagnostic preparations; medical and veterinary testing preparations namelydiagnostic preparations; reagents for medical and veterinary diagnostic purposes; medical and veterinary preparations for the diagnosis of infectious diseasesblood groupingvirologyantibodiesgeneticsoncologyhepatologypharmacogeneticscardiovascular medicinerespiratory ailments; diagnostic preparations for testing for and in relation to infectious diseasesblood groupingvirologyantibodiesgeneticsoncologyhepatologypharmacogeneticscardiovascular medicinerespiratory ailments; diagnostic kits comprised of medical diagnostic reagents and assays for testing of biological samples in the nature of tissue and bodily fluids and food samples for use in disease detectionfor and in relation to infectious diseasesblood groupingvirologyantibodiesgeneticsoncologyhepatologypharmacogeneticscardiovascular medicinerespiratory ailments in the medical and veterinary fields *; all of the aforesaid being preparations or substances exclusively for use in detecting bacterial infections in animals and humans as well as for detecting bacteria in food *

Publicações

Histórico de despachos e eventos da marca no USPTO.

39 publicações encontradas

C71T

CANCELLED SECTION 71

02/01/2026

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

18/06/2024

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

06/10/2021

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

21/09/2021

LIME

LIMITATION FROM THE IB EXAMINED AND ENTERED

21/01/2021

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

21/01/2021

PLGL

ASSIGNED TO PARALEGAL

21/01/2021

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

28/05/2020

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

18/10/2019

FICS

FINAL DISPOSITION NOTICE SENT TO IB

27/09/2019

FIMP

FINAL DISPOSITION PROCESSED

27/09/2019

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

18/09/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

18/06/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/04/2019

PUBO

PUBLISHED FOR OPPOSITION

02/04/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

13/03/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

22/02/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/02/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/02/2019

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

05/02/2019

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

17/12/2018

GNFR

FINAL REFUSAL E-MAILED

17/12/2018

CNFR

FINAL REFUSAL WRITTEN

17/12/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/12/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/12/2018

ALIE

ASSIGNED TO LIE

04/12/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

28/11/2018

RFNT

REFUSAL PROCESSED BY IB

23/06/2018

ATRV

ATTORNEY REVIEW COMPLETED

20/06/2018

LIME

LIMITATION FROM THE IB - REQUEST EXAM REVIEW

20/06/2018

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

15/06/2018

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

31/05/2018

RFRR

REFUSAL PROCESSED BY MPU

31/05/2018

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

24/05/2018

CNRT

NON-FINAL ACTION WRITTEN

23/05/2018

DOCK

ASSIGNED TO EXAMINER

16/05/2018

MAFR

APPLICATION FILING RECEIPT MAILED

17/04/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

13/04/2018

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/04/2018

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace ACTIPHAGE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.